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Abstract
Abdominal aortic aneurysm (AAA) is a relatively common and potentially fatal disease. The 
management of AAA has undergone extensive changes in the last two decades. High quality vascular 
surgical registries were established early and have been found to be instrumental in the evaluation and 
monitoring of these changes, most notably the wide implementation of minimally invasive 
endovascular surgical technology. Trends over the years showed the increased use of endovascular 
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early survival advantage of EVAR. Also, data from the early EVAR years changed the views on 
endoleak management and showed the importance of tracking the implementation of new techniques. 
Registry data complemented the randomized trials performed in aortic surgery by showing the high 
rate of laparotomy related reinterventions after open repair. Also, they are an essential tool for the 
understanding of outcomes in a broad patient population, evaluating the generalizability of findings 
from randomized trials and analyzing changes over time. By using large scale data over longer 
periods of time, the importance of centralization of care to high-volume centers was shown, 
particularly for open repair. Additionally, large-scale databases can offer an opportunity to assess 
practice and outcomes in patient subgroups (e.g. treatment of AAA in women and the elderly) as well 
as in rare aortic pathologies. In this review article, we point out the most important paradigm shifts in 
AAA management based on vascular registry data. 
Keywords: “Abdominal aortic aneurysm” “Endovascular Aortic Repair” “Paradigm shifts” 
“Registry” “Quality improvement” “database” 
Introduction:
Abdominal Aortic Aneurysm (AAA) is a major cause of mortality as a result of aneurysm rupture.1 
With an aortic aneurysms prevalence of 6% in males, the health burden of AAA is substantial.2 
However, a better understanding of aneurysmal disease, earlier detection, the introduction of 
minimally invasive endovascular aneurysm repair (EVAR) and increasing experience have improved 
outcomes for patients with AAA. Therefore, the management of AAA has changed radically over the 
years and is in constant evolution. 
The management of AAA has been extensively studied and guidelines have been established by the 
European Society for Vascular Surgery (ESVS) and the Society for Vascular Surgery (SVS).3,4 These 
recommendations are founded on Randomized Controlled Trials (RCT), prospective data and 
retrospective studies. Although RCTs are considered the gold standard in evaluating the effectiveness 
of a treatment, it is important to understand their inherent limitations.5 Strict inclusion and exclusion 
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study setting and conditions, with specific surgeons and centers performing operations on selected 
patients might not relate to broader clinical practice. In times where technique, technology and 
experience improve rapidly, RCT results might no longer reflect contemporary practice by the time 
they get published. Furthermore, at the time of early RCTs, when the new technology was introduced, 
long-term behavior, complications and their treatment were largely unknown and may have affected 
the results. Thus, RCTs cannot be used to answer every clinical question. Also, existing RCTs may be 
underpowered to detect differences for outcomes with low event rates. Vascular registry data can 
complement RCTs and are an essential tool for the understanding of outcomes in a broad patient 
population, evaluating the generalizability of RCT findings, rapid assessment of new technology and 
procedures, and analyzing changes over time. Registries offer data for large-scale outcome analysis, 
over longer periods of time and in multiple regions, countries or continents, enabling continuous 
assessment and improvement of AAA management. 
 
Registries are defined as an organized system that collects uniform data through observational study 
methods to evaluate outcomes for patients defined by a disease or exposure, for a predetermined 
purpose.6 The first formal vascular registry was created by DeBakey and Simeone during the World 
War II with a subsequent review of more than 2000 vascular injuries.7 Their observations on the 
treatment of vascular injuries with ligation showed high amputation rates. However, alternative 
management strategies were investigated and showed poor outcomes.7 These data caused arterial 
ligation to become the United States (US) Army policy.7 During the Korean War, Dr. Carl Hughes 
showed an important decline from the 49% amputation rates in World War II to 13% in the Korean 
War.8 The outcomes in the Korean War registry emphasized that revascularization should only be 
attempted within eight hours of injury. With the implementation of Medicare in the US in 1965, 
collection of its administrative data started. Medicare is a federal health insurance program for 
individuals in the US who are aged ≥65 years and selected younger individuals with disabilities or 
end-stage renal disease, and in 2015 over 55 million beneficiaries were covered. These data have been 
essential for providing real-world evidence among older individuals in the US. In 1966, Dr. Norman 
Rich established the Vietnam Vascular Registry (VVR) which contains information from over 7500 
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revascularizations.9,10 Data collection by National Inpatient Sample (NIS) started in 1988 and includes 
a stratified 20% random sample of all nonfederal inpatient hospital admissions throughout the US.11  
When used with adequate weighting, this database represents nearly 95% of all inpatients admissions 
in the US. The Vascular Study Group of New England (VSGNE) database was created in 2001 by 
Jack Cronenwett in New England and was followed by the launch of the Vascular Quality Initiative 
(VQI) by the Society for Vascular Surgery (SVS) in 2011. The VQI was designed to improve the 
quality, safety, effectiveness, and cost of vascular surgery and reports quality measures to physicians 
and hospitals.13
In Europe, the predecessor of the Swedish Vascular registry (Swedvasc), the Vascular Registry in 
Southern Sweden (VRISS) was established in 1987 by Sven-Erik Bergentz, David Bergqvist, Thomas 
Troëng, Eibert Einarsson and Lars Norgren and gained national coverage in 1994. This first 
population-based registry in vascular surgery has been an essential data source for research and 
enabled important quality improvement projects. In England, the Hospital Episode Statistics (HES) 
database was established in 1989 and collects information about all patients admitted to National 
Health Service hospitals in England.11 The European Collaborators on Stent-Graft Techniques for 
Abdominal Aortic Aneurysm Repair (EUROSTAR) registry was established in 1996 and has tracked 
the implementation and evolution of EVAR. In 1997, as demand for a collaborative dataset to 
compare vascular surgical practice in different countries rose, Vascunet, a combination of European 
and Australasian national and regional vascular registries, was created. In 2014, a collaboration of 
Vascunet, the SVS VQI and manufacturers formed the International Consortium of Vascular 
Registries (ICVR), combining existing vascular quality improvement registries from in America, 
Europe and Australasia.12 An overview of the administrative datasets and quality improvement 
registries employed in vascular surgical research is provided in Table 1. 
Quality improvement, administrative, and combined databases have specific limitations due to their 
distinctive designs. While quality improvement databases, such as the Swedvasc and the VQI, have 
the advantage of clear variable definitions and granularity, the voluntary basis of these registries could 
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Medicare or NIS, offer large patient numbers and often national coverage. However, inconsistency in 
coding systems and limited details are inherent limitations. Combination databases, such as Vascunet 
and ICVR, contain large patient numbers and geographic variation but are limited due to the 
heterogeneity of the databases they combine. 
In this review we describe the most important paradigm shifts in abdominal aortic aneurysm 
management originating from vascular registry studies. We will also describe potential future 
breakthroughs. Eligible manuscripts were based on registry data including quality improvement, 
administrative and combined databases.
The shifting dominance and decreasing perioperative adverse outcomes of EVAR 
The large patient samples and data collection over long periods of time make registry studies ideal 
sources for studying trends over time. Several registry studies spanning the previous four decades 
enabled the evaluation of the shift in utilization of EVAR and open surgery and showed the 
decreasing adverse outcomes over time. A study covering the last two decades of the 20th century 
showed no decrease in mortality after elective and ruptured AAA open repair (average operative 
mortality over the study period in elective repair: 5.6% and ruptured repair: 45.7%).13 However, at the 
end of the 20th century, a shift in the treatment paradigm was observed as EVAR was increasingly 
utilized.14 This trend was accelerated in the first decade of the 21st century, with EVAR use surpassing 
open repair in 2005 for elective surgery and the increasing dominance since (5.2% EVAR utilization 
in 2000; 74% EVAR in 2010).15 Decreasing 30-day mortality rates were observed for endovascular 
repair despite the higher age and rates of comorbidities in the patients undergoing EVAR compared to 
open repair (Between 1994 – 1999: 3.4% 30-day mortality after EVAR and 1.1% between 2012 - 
2016)(Table 2).14,16,17 With the increasing expansion of EVAR use, overall operative mortality for 
elective AAA repair declined (4.9% in 1995 to 2.4% in 2008).18 These findings proved that the results 
of randomized controlled trials were generalizable to the US population and justified the increased use 
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EVAR survival advantage and the importance of late outcomes and follow-up
When looking at long-term survival in registry studies, the survival advantage after EVAR compared 
to open repair persisted for approximately three years, after which it was similar to survival after open 
repair.17,19 In RCTs, with smaller patient populations, younger patients, and restricted inclusion 
criteria, this survival advantage with EVAR persisted for shorter periods of time.20–22 Also, this study 
confirmed that late rupture rates are higher after EVAR compared to open repair (5.4% after EVAR 
and 1.4% after open repair, through eight years of follow-up).17 These finding highlighted the 
importance of performing long-term follow-up after intervention. In terms of late reinterventions after 
AAA repair, analysis of Medicare data confirmed the RCT results showing higher aneurysm related 
reinterventions after EVAR compared to open repair (18.8% vs 3.7% at eight years), but for the first 
time also showed the higher rate of laparotomy related complications of hernia and bowel obstruction 
after open repair (8.2% after EVAR, 17.7% after open repair at eight years). This analysis prompted 
the RCT PIs to try to go back to find laparotomy related complications in the randomized patients as 
best as they could and these were reported subsequently.19
Registry studies using long-term follow up data also show the low annual imaging follow-up 
adherence after EVAR with less than half of the patients receiving follow-up five years after 
EVAR.23,24 Also, loss to follow-up was highest in patients undergoing urgent repair (HR: 1.27 
(95%CI 1.20-1.35).23 Despite the low costs of ultrasound surveillance, follow-up imaging still 
primarily occurred through CT surveillance (with a decrease between 2002 and 2010 from 60.8% to 
42.1%).25 These studies showed alarming trends and important opportunities for quality improvement. 
Centralization of open AAA surgery
The complexity of AAA repair procedures might warrant the centralization of these procedures to 
high-volume centers and by high-volume surgeons. In registry data from 2001-2003, the highest-
volume centers used an endovascular approach 44% of the time compared to 18% EVAR use in the 
lowest-volume centers.26 Also, ICVR data showed a clear increase in survival after open repair in 
higher-volume centers with 2.4% difference between the highest- and lowest-volume centers (Figure 
1).27 However this relationship was not evident in patients undergoing EVAR, where a decrease in 
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effect of increasing volume on mortality in the following quintiles.27,28,29 Surgeon volume had a 
similar association with perioperative mortality after EVAR and open repair.30,31 After EVAR, VQI 
data showed no effect of surgeon volume on perioperative mortality (Q1: 1.8% vs Q5: 1.6%). 
However, perioperative mortality after open repair decreased with increasing surgeon volume (Q1: 
6.4% vs. Q5: 3.8%).  For the treatment of rupture repair, Vascunet data showed that centers with 
higher volume or with a primary EVAR approach were associated with decreased perioperative 
mortality (Figure 2).32 The strong relationship between center and surgeon volume with perioperative 
mortality after open repair shown in these registry studies impacted the recommendation that open 
surgery should be centralized to high-volume centers and surgeons. 
Although perioperative death is a highly relevant quality indicator for open AAA repair, it may not be 
as appropriate for EVAR. EVAR can be considered as a minimally invasive procedure, and 
consequently has a minimal perioperative risk. Instead, there is a concern with long-term durability 
for EVAR. Therefore, the need for late reoperation and the risk of late ruptures could be more 
relevant quality markers for EVAR. This aspect needs to be incorporated into future analyzes aimed at 
studying the potential need for centralization of EVAR operations as well.
Understanding risk factors
Registry data provide a unique tool for understanding risk factors as they contain a real-life 
population and can be used for better preoperative patient selection. Risk calculators predicting 
mortality after EVAR and open repair included comorbidities, sex and age (Figure 3).33–35 This 
enables physicians to better identify high-risk patients and to guide clinical decision making. For 
specific subgroups, such as elderly patients, registry data can also help in the selection of treatment 
eligible patients. A study using the VQI data showed that elderly patients in the highest risk strata still 
had 50% survival at five years and only comprised 4% of the elderly population.36 Also, scoring 
systems based on registry data can help identify risk factors for specific complications.37,38 For 
example, Swedvasc data identified patient-related haemodynamic risk factors together with surgical 
skill and decision making as risk factors for intestinal ischaemia in 1997.36 Also, VQI data showed 
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exceeded 25 minutes during open juxtarenal AAA repair (OR: 0.4 [95%CI 0.2-0.97]).35 Thirdly, 
understanding risk factors for AAA development has created better selection possibilities for 
screening. Screening data from the Lifeline registry showed that smoking cessation and a healthy 
lifestyle were associated with lower risk for AAA.39  These screening data also showed that a large 
sample of the patients with AAA are not screening eligible under the current criteria.39 In Finish data, 
over a fifth of male patients would experience an AAA rupture before reaching the screening eligible 
age of 65 years. In male smokers this proportion was even higher with 31.7% rupturing before age 65 
(Figure 4).40 Revisions to the current screening guidelines using up-to-date registry data may 
potentially reduce these rates of rupture. Also, in the light of a decreasing prevalence of the disease 
the target group for AAA screening may need to be modified and more selectively target high risk 
groups, in order to maintain the effectiveness of screening programs.41
Endoleak management
After early aggressive treatment of endoleaks, EUROSTAR data showed that indication for 
reoperation should be dictated by aneurysm expansion.42 The EUROSTAR registry was established in 
1996 and collected data from patients undergoing infrarenal EVAR. The EUROSTAR data showed 
that persistent endoleaks, but not temporary endoleaks, were associated with sac expansion and late 
rupture.43 These results highlighted the importance of screening for endoleaks after EVAR.43  
Eurostar data also showed that type I and III endoleaks had a significant negative impact on late 
rupture but not type II, 45 this latter fact was confirmed by others, although the true long-term 
significance of type II leaks is yet to be determined.44,45 With these results, a better understanding of 
the natural history of endoleaks was achieved, hereby avoiding overtreatment by recommending 
routine follow-up for patients with type II endoleaks and reinterventions only in patients with sac 
increase. This showed the importance of following the implementation of new procedures with 
registry data and a decrease in re-intervention, primarily in coil embolization procedures (4.2% in 
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Elderly patients are often excluded in RCT studies. However, this subgroup has been studied in 
registry data, showing that treatment of AAA is often performed in elderly patients, and that patients 
over 80 years with reasonable life expectancy and quality of life can undergo elective AAA repair 
with excellent outcomes. Also, the survival benefit of EVAR over open repair, which was shown 
using Medicare data, was most pronounced in older patients (67 to 69 years old: 2.1% absolute 
perioperative mortality difference; 85 years and older: 8.5% difference) (Figure 5).19 Also, the 
increasing adoption of EVAR over the years was most dramatic in patients over age 80 and this age 
group also had the most dramatic reduction in deaths due to rupture.18 
From the Swedvasc registry, it was found that the importance of age for short-term outcome after 
AAA repair has diminished,46 and that octogenarians selected for AAA repair in fact had a superior 
long-term survival compared to the general population.47 VQI data showed excellent survival in the 
majority of elderly patients after contemporary EVAR with only 4% of the elderly population in the 
highest risk strata.36 These observations suggests that the observed change in indication that has 
occurred with the introduction of EVAR, with a dramatic increase in older patients being offered 
AAA repair in recent times, is so far a reasonable development. 
Treatment of female patients
There are concerning sex discrepancies in AAA presentation, management, and outcomes that 
disadvantage female patients. As female patients are underrepresented in clinical trials, the natural 
history of AAA in female patients is not clearly defined. Analysis of vascular registry data showed 
that female patients are treated at older age (median age 75 vs. 72 years, P<.001) and at smaller 
diameters (57 vs. 59mm, P<.001).48 Also, female patients undergo repair of rupture at smaller average 
diameters (71 vs. 79mm, P<.001) than men.48 More female patients have hostile neck characteristics 
such as shorter and more angulated necks.49 After intact repair, female patients have worse 30-day 
outcomes when undergoing EVAR (3.2% vs. 1.2%, P < .001) and open repair (8.0% vs. 4.0%, P = 
.04).48,50,51 However, this early discrepancy in survival outcome diminished over time, and survival 
after EVAR was similar in female and male patients after approximately two years.48 A vascunet-
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seen in females over 80 years of age, so elderly females benefit the most from EVAR compared to 
open surgery(1.3% vs. 9.7%).51 As a specific aneurysm diameter generally represents a relative 
greater increase in aortic diameter in women than in men, diameter might not have the same 
predictive value in female patients as in males. Registry data were therefore used to study the impact 
of aortic size index, a measure indexing aneurysm diameter to body size. In female patients, the aortic 
size index was the most important determinant of aneurysm rupture, while aneurysm diameter alone 
was the most predictive determinant of rupture in male patients (Figure 6).52 Also, in patients with a 
ruptured AAA in Sweden, female patients less often received surgery than males (58.6% vs. 78.7%, 
P < 0.001).53 These registry studies added to the understanding of sex differences in treatment of 
AAA and outcomes after repair, and showed that more well-designed sex-specific research is 
essential. 
Use outside of IFU
Patients treated with EVAR outside the Instructions For Use (IFU) criteria for the available stent 
grafts are not included in RCTs. This highlights the importance of registry data to analyze the 
performance of endografts in the general population, as they are being used currently. Registry studies 
showed that a high proportion of patients undergo EVAR outside of the IFU. When using a 
conservative definition of device IFU, 42% of patients met the criteria and even when using the most 
liberal definition of device IFU, only 69% met the criteria and suggested they may be more prone to 
sac enlargement.54 However, long-term all-cause mortality and aneurysm related mortality were 
unaffected by IFU adherence in another study.55 More data with more granular details of specific IFU 
criteria are clearly needed to define the appropriate role of EVAR outside of the manufacturers IFU
Geographic variation
Registries combining data from different countries such as Vascunet and the ICVR, or registries 
differentiating between regions such as the VQI, can provide essential information for identifying best 
practices or regions where quality improvement is needed. Large variation in patient selection for 
elective EVAR, including aneurysm size and patient risk profile is seen.56 Use of EVAR as compared 
to open repair (Range: 28% in Hungary - 79% in the US (P<0.01)) and treatment of patients over age 
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between countries.12 A potential contributor to this variation is the different healthcare reimbursement 
models, such that countries with a fee-for-service system more commonly operate at a smaller 
aneurysm size and on older patients (Figure 7).12 
Analysis of variation between regions or countries can also show geographical discrepancies and 
potential areas for quality improvement. In a study comparing outcomes in several European 
countries, mortality after EVAR was initially significantly worse in the United Kingdom compared to 
Sweden. However, with increasing uptake of EVAR combined with centralization of care in England, 
mortality rates decreased, and after 2007, no difference could be found between the two countries 
(Figure 8).57 Also, a Vascunet comparison of outcomes after ruptured AAA showed lower 
perioperative mortality in centers with a primary EVAR approach and those with higher case volume 
for open repair.32
Even within a country, patient selection and outcomes can vary widely between regions. VQI data 
from the US showed significant variations in patient selection between regions.58 When looking at 
outcomes after AAA repair, several regions did not meet in-hospital mortality benchmarks from the 
SVS guidelines (range, 0%-7%; P=.55).59 Awareness of these discrepancies is essential and should 
prompt changes in management and potentially regionalization of care for open AAA.
Treatment of ruptured AAA
Registry data of Malmö (Sweden) from 1993 highlighted the poor outcomes for ruptured AAA, with 
50% operative mortality and 85% overall mortality.60 While early RCT results did not show any 
advantage in the treatment of ruptured AAA using EVAR over open repair, Medicare research 
showed increasing utilization of EVAR over time with decreased EVAR and overall mortality. No 
increase in mortality with open repair over time was seen, suggesting the trend was most likely due to 
the utilization of EVAR with its lower operative mortality.61 A recent study using NIS data showed 
that EVAR became the dominant treatment module for ruptures AAA repair in 2014.62 When 
comparing ruptured AAA management between countries, it was observed that when aneurysm repair 
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significantly lower.63 Also, centers with an EVAR-first approach or high open repair case volumes 
showed lower perioperative adverse outcomes.32 Overall rupture rates with and without repair 
declined over time and is likely due to a combination of declining AAA prevalence; treatment of 
elderly patients with elective EVAR who previously would have been deemed unfit for repair when 
open surgery was the only option; and improved medical management.18,64,65 However, ruptured AAA 
rates in female patients declined in Finland but did not decline over time in Sweden.53,64 
Rare diseases
The research on uncommon vascular conditions such as endograft infection, internal iliac aneurysms 
or mycotic aneurysms primarily consists of case reports and small patient series.  However, the large 
patient numbers of registries enable analysis of these rare diseases. The Vascular Low Frequency 
Disease Consortium (VLFDC) allows centers world-wide to contribute de-identified patient data and 
study rare vascular diseases. This provides a platform to improve the quality and enables studies of 
rare diseases. For example, a rare but highly morbid complication of EVAR is aortic endograft 
infection. A study using data from the VLFDC showed the high morbidity (35%) and mortality (11%) 
of this complication and enabled the comparison of treatment strategies. Results suggested that the 
recommended management was surgical excision and that autogenous reconstruction was preferred 
over prosthetic graft replacement when possible.66
Similarly, even though internal iliac aneurysms are rare, the high rupture and mortality rates of 
internal iliac aneurysms make the understanding of their natural history and the adequate patient 
selection for surgical treatment essential. Through an international collaboration of vascular registries, 
Laine et al could study a large series of ruptured internal iliac aneurysms and showed that it was 
probably safe to increase the repair threshold from 3cm to 4cm.67 Another international registry study 
looking at mycotic aneurysm treatment showed that EVAR is feasible with good results in the near 
term,68 and in a Swedish nationwide study using propensity score matching it was shown that EVAR 
for mycotic AAA was associated with a significantly higher short-term survival in comparison with 
open repair, with similar incidence of late serious infection-related complications and reoperations.69 
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graft seems to be the best solution as in yet another multicenter registry-based study, which collected 
data from 56 patients with mycotic aneurysms from 6 countries, showed that after reconstruction of 
mycotic aneurysms with biological grafts, mortality was low (3/56) and reinfection rate at 26 months 
was zero.70
Future challenges and breakthroughs                                                                                                                                                                                                  
Although several registry-based studies have improved the quality of care among patients with AAA, 
registry-based studies can be improved significantly by specific maneuvers which will improve data 
validity and expand the data crucial to AAA research.
Future breakthroughs in registry research will come from improving registry participations, 
partnerships with different stakeholders and linkage of data. 
The incorporation of registry data as elements in the electronic health records will be an essential 
breakthrough in registry research. Directly using electronic medical records data will improve the 
accuracy of the data and standardization of data collection. 
An important challenge will be to diminish financial obstacles associated with participating in a 
vascular registry and therefore potential for bias. Also, harmonization of variable definitions across 
registries will be essential to advance collaborations and currently presents a challenge for established 
registries to update data elements. 
Through partnerships with different stakeholders and linkage of data, registry data can reach its full 
potential. An ongoing project linking data from the VQI and Medicare databases (The Vascular 
Implant Surveillance and Interventional Outcomes Network (VISION) database) combines the 
clinical, anatomical and procedural granularity from a prospective vascular-specific database with 
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An important shift in the interpretation of vascular registry research will come from the way quality is 
measured. Although mortality is the most common outcome measure in current studies and is likely 
appropriate for measuring quality after open AAA repair, it does not adequately discriminate high 
from low quality EVAR. Other important quality indicators such as rate of conversion from EVAR to 
open repair, late rupture, adherence to IFU, follow-up compliance, endoleak rates, or reinterventions 
should be considered when evaluating EVAR but the appropriate metrics are yet to be defined. 
Therefore, collection of these outcomes by registries and determination of the appropriate quality 
indicators will be essential. 
Conclusion
The continuous and rapid technological progress in aortic surgery and the exponential growth in 
knowledge has caused dramatic changes in the management of patients with AAA. Furthermore, 
registries provide data to study the changes in epidemiology, treatments and outcomes over time. By 
understanding the strengths and limitations of vascular registries, researchers can use them to improve 
quality, to develop management guidelines, and to compliment outcomes from RCTs. 
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Name Coverage 
Administrative datasets  
Medicare US population of Medicare beneficiaries (>65 years) 
Hospital episode 
statistics 
National Health Service (NHS) hospitals in England 
National inpatient 
sample 




Swedvasc National coverage for vascular surgery in Sweden 
EUROSTAR Participating centers in Europe 




Vascunet European and Australasian national and regional 
vascular registries 
ICVR# Transatlantic collaboration of vascular registries (SVS-
VQI and Vascunet) 
*SVS-VQI: Society for vascular surgery quality improvement registry; ICVR: International 
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 1994-1999 2000-2005 2006-2011 2012-2016 
Proportion of repairs with EVAR     
Intact AAA  6% 19% 47% 63% 
Ruptured AAA  1% 5% 19% 37% 
30-day mortality     
Intact EVAR 3.4% 3.9% 1.2% 1.1% 
Intact open repair 6.2% 7.7% 3.1% 2.5% 
Ruptured EVAR 68.8% 31.1% 20.6% 21.2% 
Ruptured open repair 45.6% 47.3% 30.4% 28.1% 
EVAR=Endovascular aneurysm repair. AAA=Abdominal aortic aneurysm. Source: Swedvasc 
reports and Bergqvist D, Mani K, Troëng T, Wanhainen A. Treatment of aortic aneurysms 










19-0800 figure legends 
 
Figure 1: Risk-adjusted analysis of volume impact on in-hospital mortality after EVAR and open repair 
of intact and ruptured abdominal aortic aneurysms using ICVR data. 
Reproduced from Scali ST, Beck AW, Sedrakyan A, Mao J, Venermo M, Faizer R, et al. Hospital 
Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International 
Consortium of Vascular Registries. Circulation. 2019 Oct 8;140(15):1285–7. 
 
Figure 2: Ruptured AAA perioperative mortality and EVAR % per center and volume in the Vascunet 
registry. 
Reproduced from Budtz-Lilly J, Björck M, Venermo M, Debus S, Behrendt C-A, Altreuther M, et al. 
Editor’s Choice – The Impact of Centralisation and Endovascular Aneurysm Repair on Treatment of 
Ruptured Abdominal Aortic Aneurysms Based on International Registries. European Journal of 
Vascular and Endovascular Surgery. 2018 Aug;56(2):181–8. 
 
Figure 3: Mortality Risk Score after EVAR or open repair using Medicare data. 
Reproduced from Giles KA, Schermerhorn ML, O’Malley AJ, Cotterill P, Jhaveri A, Pomposelli F, et al. 
Risk prediction for perioperative mortality of endovascular versus open repair of abdominal aortic 
aneurysms using the Medicare population. J Vasc Surg Off Publ Soc Vasc Surg Int Soc Cardiovasc Surg 
North Am Chapter. 2009 Aug;50(2):256–62. 
 
Figure 4: Ruptured AAA frequency in relation to patients' age in Finland.  
Reproduced from Laine MT, Vänttinen T, Kantonen I, Halmesmäki K, Weselius EM, Laukontaus S, et 
al. Rupture of Abdominal Aortic Aneurysms in Patients Under Screening Age and Elective Repair 
Threshold. Eur J Vasc Endovasc Surg. 2016 Apr 1;51(4):511–6. 
 
Figure 5: Survival after EVAR and open repair, per age group in Medicare data.  
Reproduced from Schermerhorn ML, Cotterill P. Endovascular vs. Open Repair of Abdominal Aortic 
Aneurysms in the Medicare Population. N Engl J Med. 2008;11. 
 
Figure 6: Distribution of ruptured repair as a function of aortic diameter (A) and aortic size index (B) 
using VQI data. 
Reproduced from Lo RC, Lu B, Fokkema MTM, Conrad M, Patel VI, Fillinger M, et al. Relative 
importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in 
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